Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC
NCT02771405Phase 3Completed
- Sponsor
- National Hepatology and Tropical Medicine Research Institute
- Start
- Mar 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sofosbuvir in hepatitis C virus infection (4 arms), sponsored by National Hepatology and Tropical Medicine Research Institute. Primary endpoint: Sustained Virologic Response 12 Weeks After Treatment. Started Mar 2016; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT02771405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02771405.